Northview Ventures

Northview LifeSciences is a principal investment and consulting firm based in Vancouver, Canada, with a focus on the life sciences sector. The firm, previously known as NorthView Ventures Inc., specializes in strategic investments while also offering consulting services that include strategy development, market research, and transactional support. The team comprises former investment bankers and biotech executives who possess extensive experience in capital markets, finance strategy, and business development. This expertise allows Northview LifeSciences to provide practical guidance grounded in real-world transactional experience, effectively supporting clients in their business development activities within the life sciences industry.

Douglas Janzen

Co-Founder and Managing Director

18 past transactions

The Medical Aesthetics Group

Venture Round in 2024
The Medical Aesthetics Group is a consultancy firm focused on the medical aesthetics industry. It specializes in offering tailored business plans and recruitment services to its clients. By providing expertise and resources, the company aims to help clients enhance revenue, promote growth, and improve overall profitability and operational effectiveness. Through its customized approach, The Medical Aesthetics Group addresses the unique needs of businesses within the medical aesthetics sector, fostering their development and success in a competitive market.

Amp Human

Venture Round in 2023
Amp Human is a venture-backed startup headquartered in Park City, Utah, focused on developing innovative products that enhance human performance. The company specializes in electrolyte lotion products designed to address acid buildup during physical exertion. Utilizing a proprietary skin absorption technology, Amp Human's offerings provide the body with additional bicarbonate to help neutralize muscle acid, thereby enabling athletes to optimize their performance regardless of their physiological limitations. By creating a new category of performance-enhancing products, Amp Human aims to support individuals in pushing their boundaries and achieving their potential.

Abdera Therapeutics

Series A in 2023
Abdera is an oncology company developing targeted alpha therapies for patients with relapsed, refractory, or metastatic cancers. Its precision oncology platform integrates drug development and antibody engineering technologies to create novel radiopharmaceuticals that specifically target tumors while minimizing systemic toxicities.

Abdera Therapeutics

Series B in 2023
Abdera is an oncology company developing targeted alpha therapies for patients with relapsed, refractory, or metastatic cancers. Its precision oncology platform integrates drug development and antibody engineering technologies to create novel radiopharmaceuticals that specifically target tumors while minimizing systemic toxicities.

Deep Surface AI

Venture Round in 2023
Deep Surface AI develops intelligent morphing software that uses advanced machine learning algorithms to generate personalized, realistic 3D visualizations for facial aesthetics. This enables surgeons to provide patients with detailed, accurate representations of potential cosmetic surgery outcomes.

MindMics

Venture Round in 2023
MindMics is an emerging wearable company developing an in-ear, sound-based health monitoring platform that uses earbuds and hearing aids to measure biometrics in real time, including heartbeat, breathing, circadian rhythms, and body temperature, with the goal of supporting mental performance, focus, mindfulness, and overall well-being.

Artah

Venture Round in 2023
Artah provides personalized health consultation services aimed at enhancing clients' energy, well-being, and overall performance. They offer transformative health plans, immersive retreats, and one-to-one/group coaching programs to help individuals achieve their health goals.

Total Flow Medical

Seed Round in 2022
Total Flow Medical is a medical device startup focused on extending and improving the quality of life for cardiac surgery and life-support patients. It develops novel devices to prevent injury for patients requiring extracorporeal circulation, with its initial product being an easy-to-use cannula for minimally invasive cardiopulmonary bypass surgery, designed to reduce injury and death during invasive CPB procedures.

Elevate Farms

Series A in 2020
Elevate Farms Inc. is a technology-driven company based in Toronto, Canada, that specializes in vertically stacked indoor farming, primarily focusing on the mass production of leafy green vegetables. Founded in 2017, the company employs proprietary technology to optimize plant growth and enhance space utilization, utilizing state-of-the-art LED lighting, automated nutrient delivery systems, and climate-controlled environments. This innovative approach allows Elevate Farms to produce high-quality crops while using up to 95% less water and significantly less land than traditional farming methods. Committed to sustainability, the company strives to minimize its environmental footprint through energy-efficient designs and solar integration. Elevate Farms has demonstrated the profitability and scalability of vertical farming, operating production facilities that deliver fresh produce directly to markets, thus reducing transportation costs and improving supply chain efficiencies. With operational sites in three countries and plans for further expansion, Elevate Farms aims to meet the growing global demand for sustainable produce while addressing food security challenges.

CareSpan Health

Venture Round in 2016
CareSpan Health is a virtual healthcare clinic offering full medical care to patients remotely via its digital care platform. This platform integrates various tools and services, addressing shortages in primary, urgent, behavioral, and mental health care.

Renaissance BioScience

Venture Round in 2016
Renaissance BioScience is a Vancouver-based biotechnology company specializing in proprietary yeast-based platform technologies for applications in food and beverage, health, agriculture, and chemicals. Its portfolio includes commercial yeast strains that reduce acrylamide formation in carbohydrate-rich foods and coffee, as well as strains that prevent hydrogen sulfide in wine, beer, and cider. The company also develops RNA interference related products, including oral delivery systems for RNA and RNAi production and delivery for gastrointestinal therapies in both human and animal health, with potential use as biopesticides. Founded in 2013, Renaissance BioScience combines whole-organism and gene-targeted engineering to create optimized yeast that functions as active, market-ready microbes across global markets.

CureVac

Series F in 2015
CureVac is a biopharmaceutical company developing transformative medicines using messenger RNA (mRNA). Its product pipeline includes cancer immunotherapies, prophylactic vaccines against infectious diseases, molecular therapies for various indications, and mRNA-encoded antibodies.

Precision NanoSystem

Series A in 2015
Precision Nanosystems specializes in the development of tools and processes for the creation and manufacturing of nanoparticles used in medicine and medical research. The company offers a range of products, including the NanoAssemblr benchtop instrument, which facilitates the prototyping of nanoparticles and the development of nanoparticle-based drugs that deliver RNA, small molecules, and protein therapeutics. Additionally, Precision Nanosystems provides various kits, such as Neuro9Kit for studying gene function in neurons and glial cells, Test9Kit for gene function studies in diverse cell types, and Hepato9Kit for liver gene function analysis. Their microfluidic devices enable the rapid and cost-effective manufacturing of lipid nanoparticles that can encapsulate and deliver bioactive agents, supporting life sciences researchers in developing innovative treatments and therapies for various diseases.

Perimeter Medical Imaging AI

Series A in 2015
Perimeter Medical Imaging AI is a medical technology company focused on revolutionizing cancer surgery through the development of ultra-high-resolution, real-time imaging tools. These advanced imaging solutions are designed to address significant unmet medical needs in the surgical field, enhancing the ability to detect and delineate cancerous tissues during procedures. By improving the accuracy of surgical interventions, Perimeter aims to optimize patient outcomes and contribute to more effective cancer treatment strategies.

Synaptive Medical

Venture Round in 2015
Synaptive Medical develops integrated systems for neurosurgery, medical imaging, and surgical navigation. Its products enable interdisciplinary collaboration among healthcare professionals, focusing on patient outcomes through advanced tools for surgical planning, navigation, and visualization.

AbCellera

Venture Round in 2015
AbCellera is an antibody discovery and development company that addresses conventional barriers to find optimal clinical candidates swiftly and efficiently. Its integrated platform combines diverse antibodies, expert selection, proprietary tools, and advanced data science to deliver developable leads quickly, setting partners up for long-term success.

Aequus Pharmaceuticals

Funding Round in 2014
Aequus Pharmaceuticals, based in Vancouver, Canada, specializes in enhancing delivery methods for approved drugs and select consumer products. Its primary focus is on improving compliance, reducing dosing frequency, mitigating side effects, and enhancing commercial presentation.

Xenon Pharmaceuticals

Venture Round in 2014
Xenon Pharmaceuticals is a biopharmaceutical company dedicated to developing novel medicines for neurological disorders. It focuses on rare genetic defects as drug targets, leveraging its proprietary discovery platform called Extreme Genetics. The company's pipeline includes XEN1101 and XEN496 for epilepsy treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.